If your cold symptoms won't quit, you may have something else. Doctors explain what it could mean if you've got a lingering ...

An estimated 5,000 people in the United States are living with Eosinophilic Granulomatosis with Polyangiitis (EGPA), a rare ...

Trusted source of information on Respiratory Disorders that includes articles, news, videos, animations, quizzes, calculators and drugs.

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment ...

On Tuesday at about 10:45 a.m., the North Medford High School gymnasium roof collapsed under an estimated 700,000 pounds of snow, according to the Medford School District. Plans to modernize three ...

Related: Ozempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kind Opioid addiction, or opioid use disorder, is a public health crisis in the U.S. In 2022, 76 ...

LUBBOCK, Texas (KCBD) - The nasal spray Spravato, also known as esketamine, now acts as a first-of-its-kind treatment for those who have seen minimal or no improvement from at least two ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...